HuGE Literature Finder
Records
1
-
17
CT Texture Analysis: A Potential Biomarker for Evaluating KRAS Mutational Status in Colorectal Cancer. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 2020 Dec 35 (4): 306-314. Cao Jian, Wang Guo Rong, Wang Zhi Wei, Jin Zheng |
Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy. Targeted oncology 2020 1 15 (1): 101-113. Olbryt Magdalena, Pig?owski Wojciech, Rajczykowski Marcin, Pfeifer Aleksandra, Student Sebastian, Fiszer-Kierzkowska An |
Effectiveness of a genetic test panel designed for gynecological cancer: an exploratory study. Medical oncology (Northwood, London, England) 2019 May 36 (7): 62. Ida Koichi, Miyamoto Tsutomu, Higuchi Shotaro, Takeuchi Hodaka, Yamada Satoshi, Ono Motoki, Nishihara Hiroshi, Shiozawa Tan |
Risk Stratification and Targets in Multiple Myeloma: From Genomics to the Bedside. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 May (38): 675-680. Perrot Aurore, Corre Jill, Avet-Loiseau Her |
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population. Oncology letters 2017 May 13 (5): 3608-3616. Hao Yi-Xin, Li Yong-Mei, Ye Ming, Guo Yan-Yan, Li Qiu-Wen, Peng Xiu-Mei, Wang Qi, Zhang Shu-Fang, Zhao Hui-Xia, Zhang He, Li Guang-Hui, Zhu Jian-Hua, Xiao Wen-H |
A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Dec . Bonin Serena, Donada Marisa, Bussolati Gianni, Nardon Ermanno, Annaratone Laura, Pichler Martin, Chiaravalli Anna Maria, Capella Carlo, Hoefler Gerald, Stanta Giorg |
KRAS polymorphisms are associated with survival of CRC in Chinese population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Oct . Dai Qiong, Wei Hui Lian, Huang Juan, Zhou Tie Jun, Chai Li, Yang Zhi-H |
Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value. Pancreas 2015 Apr 44 (3): 484-92. Kwon Mi Jung, Jeon Jang Yong, Park Hye-Rim, Nam Eun Sook, Cho Seong Jin, Shin Hyung Sik, Kwon Ji Hyun, Kim Joo Seop, Han Boram, Kim Dong Hoon, Choi Yoon- |
Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol. Haematologica 2015 Feb 100 (2): 214-22. Bolli Niccolò, Manes Nicla, McKerrell Thomas, Chi Jianxiang, Park Naomi, Gundem Gunes, Quail Michael A, Sathiaseelan Vijitha, Herman Bram, Crawley Charles, Craig Jenny I O, Conte Natalie, Grove Carolyn, Papaemmanuil Elli, Campbell Peter J, Varela Ignacio, Costeas Paul, Vassiliou George |
Decreasing relapse in colorectal cancer patients treated with cetuximab by using the activating KRAS detection chip. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Oct 35 (10): 9639-47. Huang Ming-Yii, Liu Hsueh-Chiao, Yen Li-Chen, Chang Jia-Yuan, Huang Jian-Jhang, Wang Jaw-Yuan, Lin Shiu- |
Detection of activated KRAS from cancer patient peripheral blood using a weighted enzymatic chip array. Journal of translational medicine 2014 12 (1): 147. Huang Ming-Yii, Liu Hsueh-Chiao, Yen Li-Chen, Chang Jia-Yuan, Huang Jian-Jhang, Wang Jaw-Yuan, Hsiao Chao-Peng, Lin Shiu- |
[Correlation between expression of TUBB3/STMN1 and EGFR signaling pathway in non-small cell lung cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2013 Oct 16 (10): 547-52. Wang Bo, Wang Bin, Zhang Lianbin, Chu Xiangyang, Yu Ga |
[Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system]. Zhonghua bing li xue za zhi Chinese journal of pathology 2012 Oct 41 (10): 652-6. Gao Jie, Chen Jia-qi, Zhang Li, Liang Zhi-yo |
KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer. British journal of cancer 2012 Aug 107 (4): 626-31. Malapelle U, Carlomagno C, Salatiello M, De Stefano A, De Luca C, Bianco R, Marciano R, Cimminiello C, Bellevicine C, De Placido S, Troncone |
KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13. Diagnostic molecular pathology : the American journal of surgical pathology, part B 2012 Mar 21 (1): 14-23. Bihl Michel P, Hoeller Sylvia, Andreozzi Maria Carla, Foerster Anja, Rufle Alexander, Tornillo Luigi, Terracciano Lui |
[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer]. Magyar onkologia 2011 Jun 55 (2): 99-100, 102-4. Hegedûs Zita, Barbai Tamás, Tátrai Péter, Hegedûs Balázs, Kiss András, Rásó Erzsébet, Bodoky Györ |
KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography. Cancer biomarkers : section A of Disease markers 2011 11 8 (6): 331-40. Karim Bougatef, Florence Coulet, Kamel Rouissi, Nadia Kourda, Ines Omrane, Raja Marrakchi, Sarra Ben Jileni, Florent Soubrier, Amel Ben Ammar-Elgaai |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: